CClinicalTrials.gg
CompletedNCT06107530Updated Jul 23, 2025

Living a Pregnancy After a Peri-natal Grief: How Well Does Pregnancy Follow-up Meet Women's Needs and Expectations?

An interventional study of semi structured interview in Pregnancy Related, sponsored by Fondation Hôpital Saint-Joseph. Completed at 1 site in France. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-07-23.

Sponsored by Fondation Hôpital Saint-Joseph · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
9
Allocation
Not applicable
Ages
18 Years and older
Sex
Female
01

Study summary

Every year in France, around 7,000 children are born without life, following a medical termination of pregnancy (IMG), fetal death in utero (FDIU) or premature delivery ("late miscarriage"). For families affected by perinatal bereavement, the pregnancy that follows this silent birth is a moment apart, between anguish and guilt, joy and apprehension. The aim of this research project is to improve the understanding of what women go through during the pregnancy that follows, with a view to proposing a practical tool for the professionals who take care of them, in order to improve and personalize their follow-up.

02

Conditions studied

  • Pregnancy Related

Keywords

  • peri-natal loss
  • pregnancy follow up
03

In context

Lead sponsor

Fondation Hôpital Saint-Joseph is the lead sponsor of 335 studies on the registry; 48 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women who have given birth to a stillborn child (singleton or twin pregnancies):

    • delivery following fetal death in utero or medical termination of pregnancy at 15 weeks gestational age and later
    • extreme preterm birth ("late miscarriage") from 15 weeks gestational age Patient who subsequently carried a pregnancy to term and gave birth to a live, viable child between 2020 and 2023.
  • French-speaking patient
  • Patient who does not object to her participation in this research study

Exclusion criteria

Exclusion Criteria:

  • Women who have experienced a natural termination of pregnancy ("early miscarriage") before 15 weeks of amenorrhea.
  • Women who have given birth by suction in the operating theatre.
  • Women who are pregnant with twins in the pregnancy following bereavement. Patient under guardianship or curatorship
  • Patient deprived of liberty
  • Patient under court protection
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
9 participants (actual)

Study arms

  • Experimental
    Semi structured interview

    Other: semi structured interview

Interventions

  • Othersemi structured interview

    Women fulfilling the inclusion / exclusion criteria will be asked to participate to a semi structured interview with a psychiatrist or a psychologist

06

What researchers measure

Primary outcomes

  1. Identify women's specific needs and expectations for the follow-up of this particular pregnancy

    Time frame: 4months

07

Study locations

1 site
  • Fondation hôpital Saint Joseph
    Paris, 75014, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06107530
Lead sponsor
Fondation Hôpital Saint-Joseph
Responsible party
Sponsor
First posted
Oct 30, 2023
Start date
Oct 9, 2023
Primary completion
Jan 30, 2024
Completion
Mar 30, 2024
Last update
Jul 23, 2025

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion